Overcoming multidimensional immunotherapy resistance in PDAC: from microenvironment to clinic

Frontiers in Immunology 2026 Open access

Read full text
Authors: Jin Yan, Huiyi Ou, Shuai Wang, Kaizhou Jin, Xiaoyan Yu, Weiding Wu
DOI: 10.3389/fimmu.2026.1782960
Cited by: 3
References: 88

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, with immunotherapy yielding

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Cancer Immunotherapy and Biomarkers interferon and immune responses

Publication details

Journal / source
Frontiers in Immunology
Publisher
Frontiers Media SA
Volume
17
Pages
1782960–1782960
Publication date
18 March 2026
Language
EN